Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 4, 2003, Pages 424-428

  Suligoi, Barbara ^a   Massi, Mario ^b   Galli, Claudio ^d   Sciandra, Mauro ^e   Di Sora, Fiorella ^c   Pezzotti, Patrizio ^a   Recchia, Olga ^b   Montella, Francesco ^c   Sinicco, Alessandro ^e   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Patologia Clinica   (Italy)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^d ABBOTT DIAGNOSTICS   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

AIDS; Antibody avidity; AxSYM; Diagnostic test; HIV; Incidence; Surveillance

Indexed keywords

BUFFER; GUANIDINE; PHOSPHATE; SODIUM CHLORIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; AUTOMATION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0037377797     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304010-00012     Document Type: Article

References (11)

1. Rutehrford GW, Schwarcz SK, McFarland W. Surveillance for incident HIV infection: new technology and new opportunities. J Acquir Immune Defic Syndr 2000;25(suppl 2):S115-9.
2. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8.
3. Parekh B, Pau C-P, Kennedy S, et al. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection. AIDS Res Hum Retroviruses 2001;17: 137-46.
4. Schwarcz S, Kellogg T, McFarland W, et al. Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion. Am J Epidemiol 2001;153:925-34.
5. Machado DM, Delwart EL, Diaz RS, et al. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 recently infected blood donors. AIDS 2002;16: 113-9.
6. Riou M, Renier G, Mattman S, et al. Etude dynamique de l'avidité des anticorps anti-VIH lors de la renstauration de l'immunité cellulaire sous traitement antirétroviral. Ann Biol Clin (Paris) 2000; 58:715-20.
7. Le Guillou H, Le Meur A, Bourdon S, et al. Avidité des anticorps: application au diagnostic d'infection récente à VIH. Ann Biol Clin (Paris) 2001;59:41-7.
8. Jenum PA, Stray-Pedersen B, Gundersen A-G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997;35:1972-7.
9. Eggers M, Baeder U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000;60:324-30.
10. Eisen HN, Siskind GW. Variations in affinities of antibodies during the immune response. Biochemistry 1964;7:996-1008.
11. Cleveland WS. Robust locally weighted regression and smoothing scatter plots. J Am Stat Assoc 1979;74:829-36.